Correlation Between Milestone Pharmaceuticals and Annovis Bio
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Annovis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Annovis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Annovis Bio, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Annovis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Annovis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Annovis Bio.
Diversification Opportunities for Milestone Pharmaceuticals and Annovis Bio
-0.66 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Annovis is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Annovis Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annovis Bio and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Annovis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annovis Bio has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Annovis Bio go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Annovis Bio
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.32 times more return on investment than Annovis Bio. However, Milestone Pharmaceuticals is 1.32 times more volatile than Annovis Bio. It trades about 0.28 of its potential returns per unit of risk. Annovis Bio is currently generating about -0.5 per unit of risk. If you would invest 145.00 in Milestone Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 40.00 from holding Milestone Pharmaceuticals or generate 27.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Annovis Bio
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Annovis Bio |
Milestone Pharmaceuticals and Annovis Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Annovis Bio
The main advantage of trading using opposite Milestone Pharmaceuticals and Annovis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Annovis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will offset losses from the drop in Annovis Bio's long position.The idea behind Milestone Pharmaceuticals and Annovis Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Annovis Bio vs. Bright Minds Biosciences | Annovis Bio vs. HP Inc | Annovis Bio vs. Intel | Annovis Bio vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |